scholarly journals Bone Marrow Stromal Cells With Exercise and Thyroid Hormone Effect on Post-Stroke Injuries in Middle-aged Mice

Author(s):  
Kobra Akhoundzadeh ◽  
Abedin Vakili ◽  
Hamid Reza Sameni
Author(s):  
Daqian Wan ◽  
Songtao Ai ◽  
Huoniu Ouyang ◽  
Liming Cheng

AbstractSenile osteoporosis can cause bone fragility and increased fracture risks and has been one of the most prevalent and severe diseases affecting the elderly population. Bone formation depends on the proper osteogenic differentiation of bone marrow stromal cells (BMSCs) in the bone marrow microenvironment, which is generated by the functional relationship among different cell types in the bone marrow. With aging, bone marrow provides signals that repress osteogenesis. Finding the signals that oppose BMSC osteogenic differentiation from the bone marrow microenvironment and identifying the abnormal changes in BMSCs with aging are key to elucidating the mechanisms of senile osteoporosis. In a pilot experiment, we found that 4-1BBL and 4-1BB were more abundant in bone marrow from aged (18-month-old) mice than young (6-month-old) mice. Meanwhile, significant bone loss was observed in aged mice compared with young mice. However, very little data have been generated regarding whether high-level 4-1BB/4-1BBL in bone marrow was associated with bone loss in aged mice. In the current study, we found upregulation of 4-1BB in the BMSCs of aged mice, which resulted in the attenuation of the osteogenic differentiation potential of BMSCs from aged mice via the p38 MAPK-Dkk1 pathway. More importantly, bone loss of aged mice could be rescued through the blockade of 4-1BB signaling in vivo. Our study will benefit not only our understanding of the pathogenesis of age-related trabecular bone loss but also the search for new targets to treat senile osteoporosis.


Blood ◽  
2017 ◽  
Vol 130 (Suppl_1) ◽  
pp. 92-92
Author(s):  
Pratibha Singh ◽  
Melissa A Kacena ◽  
Christie M. Orschell ◽  
Louis M. Pelus

Abstract Aging impairs hematopoietic stem cell (HSC) function by reducing their regeneration potential and skewing differentiation towards the myeloid lineage, leading to anemia, decreased immune function, and increased propensity for hematologic malignancies. While stem cell intrinsic mechanisms are known to contribute to HSC aging, it is not well understood whether age-related changes in bone marrow niches also contribute to HSC aging. Recent studies have shown that mesenchymal stem cells (MSC) form a crucial component of the HSC niche, promoting HSC quiescence and balanced differentiation. We recently discovered that deficiency of CXCR4 expression on bone marrow stromal cells and Nestin+ MSCs reduces hematopoietic regeneration after HSC transplantation. Whether impairment of CXCR4/SDF-1 signaling in the aged marrow contributes to loss of HSC regenerative potential is not known. Analysis of bone marrow from aged (22-25 month) and young (3-4 month) C57BL/6 mice revealed ~55% reduction in CXCR4 expression on MSC (CD45-Ter119-CD31-CD51+PDGFR+Nestin+) and 40% reduction in CXCR4 expression on total bone marrow stromal cells (CD45-Ter119-CD31-) as measured by flow cytometry. In addition, MSC and total stromal cells from aged mice demonstrated lower expression of CXCR4 transcripts compared to MSC derived from young mice. The reduced expression of CXCR4 on MSC from aged mice was accompanied by increased expression of total and mitochondrial ROS (3-fold and 3.5-fold higher, respectively), senescence markers including p16 and b-galactosidase (2.5-fold and 2.1-fold higher, respectively) and DNA damage (2-fold higher Kap-1 phosphorylation). Aged mice demonstrated fewer total MSC in the bone marrow (2.5-fold lower) and reduced ex vivo clonal expansion (5-fold lower) measured by CFU-F formation. Furthermore, the marrow niche in aged mice produced significantly lower amounts of the HSC maintenance factors SDF-1, SCF and b-FGF. In vitro exposure of SLAM LSK cells from young mice to MSC from aged mice resulted in a higher cycling of the HSCs and reduced HSC engraftment potential by 3.2 fold, with myeloid biased differentiation observed at 6 months after competitive transplantation compared to SLAM LSK cells from young mice cultured on MSC from young mice. These data suggest that reduced expression of CXCR4 on MSC associated with aging may have functional consequences on HSC niche function leading to an aged HSC phenotype. To determine whether the loss of CXCR4 in bone marrow stromal cells/MSC drive HSC aging, we created chimeric mice by transplanting wild-type bone marrow donor cells either into tamoxifen-inducible conditional CXCR4 knockout mice or into wild-type recipients. Interestingly, bone marrow SLAM-LSK cells of chimeric mice made with CXCR4 deficient stroma demonstrated an aged phenotype including increased cycling (35% higher) and myeloid skewed differentiation compared to chimeric mice made with wild-type stroma. Furthermore, CXCR4 deletion exclusively in nestin+ MSCs also produced an aged HSC phenotype. In addition, similar to our observations with MSC from aged mice, CXCR4 deficient MSC showed higher expression of cellular and mitochondrial ROS. Since aged and CXCR4 deficient MSC exhibited higher expression of ROS, we explored whether high levels of MSC-derived ROS contributes to HSC aging. Treatment of aged or CXCR4 deficient MSC with N-acetyl-L-cysteine (NAC) for 1 week, improved their niche supporting activity including CFU-F formation and SDF-1 production and attenuated the HSC aging phenotype. In conclusion, our studies suggest that age-associated reduction in CXCR4 expression on bone marrow MSC impairs niche activity and increases ROS production, driving an HSC aging phenotype. These findings suggest that modulation of CXCR4/SDF-1 axis in MSC may lead to novel intervention to alleviate stem cell aging, thereby improving the age-associated decline in immune/hematopoietic function. Disclosures No relevant conflicts of interest to declare.


1999 ◽  
Vol 160 (1) ◽  
pp. 97-102 ◽  
Author(s):  
CH Kim ◽  
HK Kim ◽  
YK Shong ◽  
KU Lee ◽  
GS Kim

It is well known that excessive thyroid hormone in the body is associated with bone loss. However, the mechanism by which thyroid hormone affects bone turnover remains unclear. It has been shown that it stimulates osteoclastic bone resorption indirectly via unknown mediators secreted by osteoblasts. To determine if interleukin-6 (IL-6) or interleukin-11 (IL-11) could be the mediator(s) of thyroid hormone-induced bone loss, we studied the effects of 3,5,3'-tri-iodothyronine (T3) on basal and interleukin-1 (IL-1)-stimulated IL-6/IL-11 production in primary cultured human bone marrow stromal cells. T3 at 10(-12)-10(-8) M concentration significantly increased basal IL-6 production in a dose-dependent manner. It also had an additive effect on IL-1-stimulated IL-6 production, but failed to elicit a detectable effect on basal or IL-1-stimulated IL-11 production. Treatment with 17beta-estradiol (10(-8) M) did not affect the action of T3 on IL-6/IL-11 production. These results suggest that thyroid hormone may stimulate bone resorption by increasing basal and IL-1-induced IL-6 production from osteoblast-lineage cells, and these effects are independent of estrogen status.


2013 ◽  
Author(s):  
Sylvia Thiele ◽  
Alexander Rauch ◽  
Jan P Tuckermann ◽  
Lorenz C Hofbauer ◽  
Martina Rauner

Sign in / Sign up

Export Citation Format

Share Document